Older Adults with Type 2 Diabetes (T2D) Experience Less Hypoglycemia when Switching to Insulin Glargine 300 U/mL (Gla-300) vs. Other Basal Insulins (DELIVER 3 Study)

被引:0
|
作者
Zhou, Fang Liz
Ye, Fen
Gupta, Vineet
Gupta, Rishab
Sung, Jennifer
Berhanu, Paulos
Blonde, Lawrence
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
986-P
引用
收藏
页码:A256 / A256
页数:1
相关论文
共 50 条
  • [21] Insulin Glargine 300 U/mL (Gla-300) vs 100 U/mL (Gla-100) in older people with T2Dm: Results from a randomized trial
    Ritzel, Robert
    Vonbank, Alexander
    Espinasse, Melanie
    Muehlen-Bartmer, Ingrid
    Zhang, Nue
    Munshi, Medha
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 369 - 369
  • [22] Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
    Dirk Müller-Wieland
    Nick Freemantle
    Riccardo C. Bonadonna
    Celine Mauquoi
    Gregory Bigot
    Mireille Bonnemaire
    Pierre Gourdy
    Didac Mauricio
    Diabetes Therapy, 2023, 14 : 401 - 413
  • [23] Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
    Mueller-Wieland, Dirk
    Freemantle, Nick
    Bonadonna, Riccardo C.
    Mauquoi, Celine
    Bigot, Gregory
    Bonnemaire, Mireille
    Gourdy, Pierre
    Mauricio, Didac
    DIABETES THERAPY, 2023, 14 (02) : 401 - 413
  • [24] Device-Supported vs. Routine Titration of Insulin Glargine 300 U/mL (Gla-300) in T2DM: Efficacy and Safety
    Edelman, Steven
    Bain, Steve
    Hasslacher, Christoph
    Charpentier, Guillaume
    Vespasiani, Giacomo
    Flacke, Frank
    Goyeau, Harmonie
    Woloschak, Michael
    Davies, Melanie
    DIABETES, 2017, 66 : LB34 - LB34
  • [25] Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL (Gla-300) vs. Glargine 100 U/mL (Gla-100) in Type 2 Diabetes (T2DM) in a Patient-Level Meta-analysis of 1-Yr Phase 3a EDITION Studies
    Ritzel, Robert
    Roussel, Ronan
    Giaccari, Andrea
    Vora, Jiten P.
    Grisoni, Marie-Lise
    Brulle-Wohlhueter, Claire
    Glezer, Stanislav
    Yki-Jazrvinen, Hannele
    DIABETES, 2015, 64 : A264 - A264
  • [26] Is hypoglycaemia a modifiable patient risk in type 2 diabetes: A pooled analysis of insulin glargine 300 U/mL (Gla-300) vs 100U/mL (Gla-100) trials?
    Zhang, Q.
    Rosenstock, J.
    Gerrits, C.
    Liao, L.
    Chew, P.
    DIABETOLOGIA, 2015, 58 : S472 - S472
  • [27] Glycemic Control in People with Type 2 Diabetes (PWT2D) Switching from NPH to Insulin Glargine 300 U/mL (Gla-300) : REALI Pooled Database
    Mueller-Wieland, Dirk
    Freemantle, Nick
    Bonadonna, Riccardo C.
    Mauquoi, Celine
    Bigot, Gregory
    Bonnemaire, Mireille
    Gourdy, Pierre
    Mauricio, Didac
    DIABETES, 2022, 71
  • [28] Treatment Satisfaction in People with Type 2 Diabetes (T2D) Receiving Basal Insulin (BI): Results from Real-World Studies and Randomized Controlled Trials (RCTs) with Insulin Glargine 300 U/mL (Gla-300)
    Harris, Stewart B.
    Snoek, Frank J.
    Meneghini, Luigi
    Lauand, Felipe, Sr.
    Westerbacka, Jukka
    de Climens, Aude Roborel
    Khunti, Kamlesh
    DIABETES, 2020, 69
  • [29] Plasma C-Peptide Concentration and Risk of Hypoglycemia in People with T2DM Treated with Insulin Glargine 300 U/mL (Gla-300) or Insulin Glargine 100 U/mL (Gla-100)
    Bolli, Geremia
    Ritzel, Robert
    Yale, Jean-Francois
    Escalada, Javier
    Davies, Melanie
    Landgraf, Wolfgang
    Bertolini, Monica
    Hecquet, Carole
    Yki-Jarvinen, Hannele
    Rosenstock, Julio
    DIABETES, 2017, 66 : A258 - A258
  • [30] Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1? generation basal insulins
    Buzzetti, Raffaella
    Fadini, Gian Paolo
    Nicolucci, Antonio
    Larosa, Monica
    Rossi, Maria Chiara
    Cucinotta, Domenico
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (09) : 2255 - 2263